Description

Pentoxifylline Prolonged Release Tablets IP 400 Mg – SUINTOL 400 PR Tablets

Description – 
SUINTOL 400 PR Tablets contain Pentoxifylline Prolonged Release Tablets IP 400 Mg in a prolonged-release formulation designed to support improved blood flow and microcirculation. The sustained-release action helps maintain therapeutic drug levels over an extended duration, supporting vascular health and circulatory function. It is commonly used in conditions associated with impaired peripheral blood circulation and vascular insufficiency.

Key Points
Prolonged Release Technology – The prolonged-release formulation ensures gradual and sustained release of Pentoxifylline, helping maintain consistent therapeutic levels for extended vascular support and improved patient compliance.

Supports Peripheral Circulation – Pentoxifylline helps improve peripheral blood flow and microcirculation, supporting better circulation in conditions associated with vascular insufficiency and reduced tissue perfusion.

Improves Oxygen Delivery – The formulation helps enhance blood flow properties and supports improved oxygen and nutrient delivery to peripheral tissues and affected areas.

Vascular & Microcirculatory Support- Useful in maintaining healthy vascular function and supporting circulatory wellness in patients requiring long-term microvascular management.

Targeted Specialties
Cardiology
General Medicine
Diabetology
Vascular Surgery
Internal Medicine
Orthopedics
Neurology

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.